Join
Live feed
·
PRReleasevia Quantisnow
VolitionRX Limited logo

VolitionRx Limited Announces the First Sale of the Nu.Q® Cancer Assays for Clinical Certification in Preparation for Routine Clinical Use

ByQuantisnow·Wall Street's wire, on your screen.
VNRX· VolitionRX Limited
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VNRX (VolitionRX Limited) and more on Quantisnow.